Antiplatelet therapy in acute myocardial infarction complicated by cardiogenic shock.
Saved in:
| Title: | Antiplatelet therapy in acute myocardial infarction complicated by cardiogenic shock. |
|---|---|
| Authors: | Dettling A; Department of Cardiology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany. a.dettling@uke.de.; German Center for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck, Hamburg, Germany. a.dettling@uke.de.; Center for Population Health Innovation, POINT, Hamburg, Germany. a.dettling@uke.de., Huber K; Faculty of Medicine, Sigmund Freud University, Vienna, Austria., Kristensen SD; Department of Cardiology, Department of Clinical Medicine, Aarhus University Hospital and Aarhus University, Aarhus, Denmark., Aradi D; Heart and Vascular Center, Semmelweis University, Budapest, Hungary., Schrage B; Department of Cardiology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.; German Center for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck, Hamburg, Germany.; Center for Population Health Innovation, POINT, Hamburg, Germany., Clemmensen P; Department of Cardiology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.; German Center for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck, Hamburg, Germany.; Center for Population Health Innovation, POINT, Hamburg, Germany. |
| Source: | Clinical research in cardiology : official journal of the German Cardiac Society [Clin Res Cardiol] 2025 Oct; Vol. 114 (10), pp. 1237-1245. Date of Electronic Publication: 2025 Mar 04. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Springer Medizin Country of Publication: Germany NLM ID: 101264123 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1861-0692 (Electronic) Linking ISSN: 18610684 NLM ISO Abbreviation: Clin Res Cardiol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
